美国多队列研究中肝脂肪变与新发心血管疾病、癌症及全因死亡的关系
研究纳入Framingham心脏研究、CARDIA研究和MESA研究的10040名参与者,用CT定义肝脂肪,评估其与新发心血管疾病、心血管死亡、新发癌症及全因死亡的纵向关联。校正基线心血管危险因素(含体重指数)后,肝脂肪变与平均随访12.7年的全因死亡相关(HR 1.21,1.04-1.40),但采用时变协变量后关联减弱;肝脂肪变与新发心血管疾病、心血管死亡及新发癌症无显著关联。
要点
- 校正基线危险因素(含BMI)后,肝脂肪变与全因死亡相关(HR 1.21,1.04-1.40)。
- 采用时变协变量后,肝脂肪变与全因死亡的关联减弱。
- 校正BMI后,肝脂肪变与新发心血管疾病无显著关联,与心血管死亡及新发癌症亦无关联。
核心结论
- 在校正基线心血管危险因素(含体重指数)后,肝脂肪变与全因死亡相关(HR 1.21,1.04-1.40),但采用时变协变量后关联减弱。
- 肝脂肪变与新发心血管疾病在考虑基线协变量或时变协变量并校正体重指数后均无统计学显著关联。
- 肝脂肪变与心血管死亡及新发癌症均无关联。
- 作者指出,在判断非酒精性脂肪性肝病与心血管疾病及死亡结局的关联时需考虑并发的心血管代谢疾病。
研究设计与样本
- 研究纳入Framingham心脏研究、年轻成人冠状动脉风险发展研究(CARDIA)和多族裔动脉粥样硬化研究(MESA)共10040名参与者,评估CT定义的肝脂肪与新发心血管疾病、心血管死亡、新发癌症及全因死亡的纵向关联。
- 采用多变量校正Cox回归模型,校正年龄、性别、糖尿病、收缩压、饮酒、吸烟、高密度脂蛋白、甘油三酯及基线或时变体重指数等协变量。
- 参与者平均年龄51.3±3.3岁,女性占50.6%,平均随访12.7年。
主要发现
- 校正基线心血管危险因素(含体重指数)后,肝脂肪变与全因死亡相关(HR 1.21,1.04-1.40),平均随访12.7年。
- 采用时变协变量后,肝脂肪变与全因死亡的关联减弱。
- 校正体重指数后,肝脂肪变与新发心血管疾病在基线协变量模型和时变协变量模型中均无统计学显著关联。
- 肝脂肪变与心血管死亡无关联。
- 肝脂肪变与新发癌症无关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: NAFLD strongly associates with cardiovascular disease (CVD) risk factors; however, the association between NAFLD and incident CVD, CVD-related mortality, incident cancer, and all-cause mortality is unclear. APPROACH AND RESULTS: We included 10,040 participants from the Framingham Heart Study, the Coronary Artery Risk Development in Young Adults Study, and the Multi-ethnic Study of Atherosclerosis to assess the longitudinal association between liver fat (defined on CT) and incident CVD, CVD-related mortality, incident cancer, and all-cause mortality. We performed multivariable-adjusted Cox regression models including age, sex, diabetes, systolic blood pressure, alcohol use, smoking, HDL, triglycerides, and body mass index at baseline or time-varying covariates. The average age was 51.3±3.3 years and 50.6% were women. Hepatic steatosis was associated with all-cause mortality after 12.7 years of mean follow-up when adjusting for baseline CVD risk factors, including body mass index (HR: 1.21, 1.04-1.40); however, the results were attenuated when utilizing time-varying covariates. The association between hepatic steatosis and incident CVD was not statistically significant after we accounted for body mass index in models considering baseline covariates or time-varying covariates. We observed no association between hepatic steatosis and CVD-related mortality or incident cancer. CONCLUSIONS: In this large, multicohort study of participants with CT-defined hepatic steatosis, accounting for change in CVD risk factors over time attenuated associations between liver fat and overall mortality or incident CVD. Our work highlights the need to consider concurrent cardiometabolic disease when determining associations between NAFLD and CVD and mortality outcomes.
引用
- Ahmed HS, Wang N, Carr JJ, et al. The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study. Hepatology. 2023. PMID: 36651168. doi:10.1097/HEP.0000000000000286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。